NPPA issues draft guidelines to tackle cases of discontinuation of scheduled formulations
Invites the industry stakeholders comments, suggestions before June 15, 2020
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
IDMA
Industry appreciate revised MSME definition, recommend for more measures
The revised definition of MSME will be effective from July 1, 2020
CDSCO observes lower supply of 15 drugs used for COVID-19 treatment
Asks drug manufacturers associations to ensure adequate production, supply and availability of these 15 drugs
Modi’s ‘self-reliance’ call need of the hour: Pharma industry
During these unprecedented times, the pharmaceutical industry has worked with the government in an integrated manner and continued…
Pharma Inc opposes 15 per cent COVID-19 anti-dumping duty on Chinese chemicals
Associations like FICCI, IDMA, FOPE have opposed CHEMEXCIL'S recommendations stating that it will adversely impact the pharma…
No separate passes required for movement of cargo across country: Government Secretary
There should not be ambiguity at the ground level and movement of trucks and goods carriers, including empty ones, to be allowed…
NPPA allows six paracetamol APIS manufacturers to export 2000 MT
Permissions have been granted to Farmson Pharmaceuticals, Meghmani LLP, Sri Krishna Pharmaceutical, Granules India, Bharat…
CDSCO extends WHO-GMP/CoPP validity by six months
The validities of WHO GMP/CoPP expiring between March to August 2020 will be extended by six months from the date of expiry of the…
Pharma sector requests time-bound relief in DPCO list citing APIs price rise
The prices of APIs used in hand sanitisers have also jumped significantly
Pharma industry seeks clarification on revised MHA guidelines for extended lockdown
The industry is wary of the penal provisions stated in the revised MHA order if certain conditions of operations are not met